⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3432318 | 0.72 | — | — | |
| SCHEMBL669845 | 0.71 | — | — | |
| SCHEMBL3901616 | 0.70 | — | — | |
| SCHEMBL5530822 | 0.70 | — | — | |
| SCHEMBL4779247 | 0.69 | — | — | |
| SCHEMBL98184 | 0.69 | — | — | |
| SCHEMBL7399126 | 0.67 | — | — | |
| SCHEMBL2791685 | 0.66 | — | — | |
| SCHEMBL96094 | 0.65 | — | — | |
| SCHEMBL6896644 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8475765-B2 | Hydroxyalkyl starch derivatives | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| US-20120046240-A9 | Method of Producing Hydroxyalkyl Starch Derivatives | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2012-02-23 | — | — | US | disclosed |
| US-20110054152-A1 | Hydroxyalkyl Starch Derivatives | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2011-03-03 | — | — | US | disclosed |
| EP-2272865-A2 | Method of producing hydroxyalkyl starch derivatives | Fresenius Kabi Deutschland GmbH (DE) | 2011-01-12 | — | — | EP | disclosed |
| US-20100317609-A1 | Method of Producing Hydroxyalkyl Starch Derivatives | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2010-12-16 | — | — | US | disclosed |
| US-7759494-B2 | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxy-carbonyl]-5-oxazolidine carboxylic acids | DABUR INDIA LIMITED (IN) | 2010-07-20 | — | — | US | disclosed |
| EP-2017287-A2 | Method of producing hydroxyalkyl starch derivatives | Fresenius Kabi Deutschland GmbH (DE) | 2009-01-21 | — | — | EP | disclosed |
| EP-1398327-B1 | Method of producing hydroxyalkyl starch derivatives | FRESENIUS KABI DE GMBH (DE) | 2008-08-27 | — | — | EP | disclosed |
| US-20080064887-A1 | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxycarbon1]-5-oxazolidine carboxylic acids | DABUR INDIA LIMITED (IN) | 2008-03-13 | — | — | US | disclosed |
| US-7247738-B2 | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids | DABUR INDIA LIMITED (IN) | 2007-07-24 | — | — | US | disclosed |
| US-20050238723-A1 | Method of producing hydroxyalkyl starch derivatives | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2005-10-27 | — | — | US | disclosed |
| WO-2004024776-A1 | METHOD OF PRODUCING HYDROXYALKYL STARCH DERIVATIVES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-03-25 | — | — | WO | disclosed |
| EP-1398328-A1 | Hydroxyalkyl starch derivatives | Fresenius Kabi Deutschland GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| EP-1398327-A1 | Method of producing hydroxyalkyl starch derivatives | Fresenius Kabi Deutschland GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-20030229135-A1 | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxycarbonyl]-5-oxazolidine carboxylic acids | DABUR PHARMA LIMITED (IN) | 2003-12-11 | — | — | US | disclosed |